Australia's largest stock trading and investment forum Australia's #1 stock forum

IMM

1.64%

30.0¢ immutep limited

Interesting that IMM have said The study’s primary endpoint is...

First 12 Last

Share
Profile

Follow
oldbull26

7,952 Posts.

63

27/01/21

15:33

Post #: 50474851
Share

Originally posted by tuts: ↑

True, anything can happen.

The scenario, fast track approval is part of the "Bob is ur uncle" scenario but the result have to be VERY decissivly significant. In that case, maybe not Phase 2b, but there will still have to be a phase 3/4, as big number of patients is needed to see efficacy accross a number of different factors, ethnicity is usually a standard factor then and also to increase number of patients in (e.g. age, disease stage etc) subgroups to have meaningful statistics.

IMM happened to enter the race not too late and at this stage and hence finding patients for the trial may not be too difficult.

Another advantage is that vaccines will need the test of time to prove their long term safety and hence a treatment option may be the preferred choice, .... and if post-treatment the auto-immune system is established, then that can be your vaccine too!!! But we do not know enough about this virus ... so, all speculation on my behalf.

Expand

Interesting that IMM have said The study’s primary endpoint is the patient’s clinical status at day 15 as per the WHO recommended evaluation scale.

The WHO evaluation is just 50% efficacy for a vaccine so 50% may also be the standard for Efti.

https://www.abc.net.au/news/2021-01-14/covid-19-vaccine-efficacy-rates-explained/13042960

IMM Price at posting: 44.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

What's causing the cost-of-living crisis, and how to navigate it

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

TLG

Talga Group wins key permit for flagship graphite mine in Sweden